Doshi, S., Kingston, H., Tseng, A. S., Chohan, B. H., Sambai, B., Guthrie, B. L., . . . Farquhar, C. (2023). SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya. Harm Reduction Journal, 20(1), . https://doi.org/10.1186/s12954-023-00754-5
Chicago-referens (17:e uppl.)Doshi, Shradha, et al. "SARS-CoV-2 Antibody Prevalence, Correlates, and Access to Harm Reduction Services Among People Who Inject Drugs Living with and Without HIV and Their Partners in Kenya." Harm Reduction Journal 20, no. 1 (2023). https://doi.org/10.1186/s12954-023-00754-5.
MLA-referens (9:e uppl.)Doshi, Shradha, et al. "SARS-CoV-2 Antibody Prevalence, Correlates, and Access to Harm Reduction Services Among People Who Inject Drugs Living with and Without HIV and Their Partners in Kenya." Harm Reduction Journal, vol. 20, no. 1, 2023, https://doi.org/10.1186/s12954-023-00754-5.
